Literature DB >> 9365157

Molecular analysis of p21 and p27 genes in human pituitary adenomas.

H Ikeda1, T Yoshimoto, N Shida.   

Abstract

Pituitary tumours develop at a high frequency in p27-knockout mice and retinoblastoma gene-knockout mice, which suggests that cell cycle regulatory genes, such as cyclin-dependent kinase inhibitor genes, are involved in the tumorigenesis of pituitary adenoma. Analysis of p21 and p27 gene abnormalities in human pituitary adenoma was performed in 28 pituitary adenomas by polymerase chain reaction-single-strand conformational polymorphism. No point mutations were detected in these genes. As no abnormalities of the p21 and p27genes were observed, and if these genes are indeed inactivated, it is likely to be via transcriptional or translational defects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365157      PMCID: PMC2228124          DOI: 10.1038/bjc.1997.521

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Frequent loss of the P16INK4a gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

2.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

3.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

4.  Developmental changes in proliferative activity of cells of the murine Rathke's pouch.

Authors:  H Ikeda; T Yoshimoto
Journal:  Cell Tissue Res       Date:  1991-01       Impact factor: 5.249

5.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

6.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

Review 7.  Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Authors:  T K MacLachlan; N Sang; A Giordano
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1995       Impact factor: 1.807

8.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

Authors:  J Y Kato; M Matsuoka; K Polyak; J Massagué; C J Sherr
Journal:  Cell       Date:  1994-11-04       Impact factor: 41.582

9.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.

Authors:  N Hu; A Gutsmann; D C Herbert; A Bradley; W H Lee; E Y Lee
Journal:  Oncogene       Date:  1994-04       Impact factor: 9.867

10.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Authors:  M V Ponce-Castañeda; M H Lee; E Latres; K Polyak; L Lacombe; K Montgomery; S Mathew; K Krauter; J Sheinfeld; J Massague
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

View more
  15 in total

1.  The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.

Authors:  J C Wilson; J J Zhu; P M Black
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.

Authors:  Chunlan Sun; Takashi Yamato; Emiko Kondo; Toru Furukawa; Hidetoshi Ikeda; Akira Horii
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

3.  Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism.

Authors:  Run Yu; Vivien Bonert; Martha Cruz-Soto; Shlomo Melmed
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Morphologic and molecular analysis of estrogen-induced pituitary tumorigenesis in targeted disruption of transforming growth factor-beta receptor type II and/or p27 mice.

Authors:  H Ikeda; T Yoshimoto; N Shida; I Miyoshi; K Nakayama; K Nakayama; M Oshima; M M Taketo
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

Review 5.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

6.  P21Waf1/Cip1 and p27Kip1 are correlated with the development and invasion of prolactinoma.

Authors:  Wei Dong; Jianhua Li; Qian Liu; Chunhui Liu; Chuzhong Li; Guidong Song; Haibo Zhu; Hua Gao; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2017-12-11       Impact factor: 4.130

7.  Aggressive vestibular schwannomas showing postoperative rapid growth - their association with decreased p27 expression.

Authors:  Ho Jun Seol; Hee-Won Jung; Sung-Hye Park; Sung-Kyun Hwang; Dong Gyu Kim; Sun Ha Paek; Young-Seob Chung; Chang Sub Lee
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

8.  Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.

Authors:  K Komatsubara; S Tahara; K Umeoka; N Sanno; A Teramoto; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

9.  p27(kip1) and Other Cell-Cycle Protein Expression in Normal and Neoplastic Endocrine Tissues.

Authors:  Lori A. Erickson
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 10.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.